$RKLB

Four Launches From 100: Rocket Lab Gets a Bullish New Call, With Iridium and Mynaric Along for the Ride

Rocket Lab (RKLB) completed its 16th Electron mission of 2026, nearing an annual launch record. Raymond James initiated coverage with an Outperform rating and $80 price target, citing growth from Neutron rocket, Mynaric acquisition, and pending Iridium (IRDM) deal. Analyst projects positive EBITDA by 2027-2028, but notes execution risks.

Original reporting
Published Sep 21, 2026, 11:51 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 21, 2026, 12:08 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Four Launches From 100: Rocket Lab Gets a Bullish New Call, With Iridium and Mynaric Along for the Ride — source image
Decision brief

The 30-second read

$RKLBBullishMed
01

Why it matters

Analyst upgrade and large acquisition signal growth but introduce execution risk.

02

Market read

New coverage and a major pending acquisition provide fresh catalysts for RKLB and IRDM, affecting the broader space‑tech sector.

03

What to watch

Potential delays in Neutron development and margin assumptions may limit near‑term gains.

Relevance 7/10Novelty 7/10Timing: recent coverage as of Sep 21 2026

Background

Rocket Lab recently completed its 16th Electron mission of 2026 and is nearing its annual launch record.

Company-level read

Ticker impact

$RKLBBullishMedium confidence
Context

Raymond James initiated coverage with an Outperform rating and $80 price target, a fresh analyst upgrade for Rocket Lab.

Expected impact

Potential 20‑30% upside over the next weeks.

Evidence & confidence

New coverage and price target provide a concrete catalyst; execution risk remains.

$IRDMNeutralMedium confidence
Context

Rocket Lab's pending $8 billion acquisition of Iridium Communications is highlighted as a major upside driver.

Expected impact

IRDM may see modest upside if acquisition clears, but volatility expected.

Evidence & confidence

Acquisition size is large; approval uncertainty tempers impact.

Market effects

Boosts outlook for small‑sat launch and satellite‑service sector.

Positive for US space‑tech equities; limited effect elsewhere.

Highlights consolidation trend in commercial space industry.

Counterpoint

Execution and integration risks could outweigh upside, leading to price disappointment.

Key entities

  • Rocket Lab Corporation

    US‑listed space launch provider (NASDAQ:RKLB).

  • Iridium Communications Inc.

    US‑listed satellite communications firm (NASDAQ:IRDM).

Related articles

$RKLBMed

Why is Rocket Lab stock surging today?

Rocket Lab's stock rose 7.7% to $69.53 as investors returned after a selloff tied to a $1.94B share offering. Cantor Fitzgerald reiterated an Overweight rating and $122 price target. SpaceX's IPO filing boosted sector sentiment. Rocket Lab's Q2 2026 revenue per launch increased to $9.1M, with a $2.36B backlog. The Nasdaq and S&P 500 also gained.

$RKLBMed

Cantor sees Rocket Lab stock as good entry point after Iridium funding

Cantor Fitzgerald maintains a bullish outlook on Rocket Lab (RKLB) after it secured funding for its Iridium acquisition. The deal, expected to close in mid-2027, aims to double combined revenue. Iridium reported $850M revenue in FY2025, with shares up 164% over the past year. Rocket Lab targets its first Neutron rocket launch this year, with Cantor modeling $900M revenue for FY2026.

$RKLBHigh

RKLB Stock Price Forecast – Why Raymond James Is Betting Big on Rocket Lab

Rocket Lab USA (RKLB) shares rose 2% pre-market after Raymond James initiated coverage with an Outperform rating and $80 price target, citing growth potential. The company completed its 16th Electron launch in 2026, deploying a satellite. Analyst Brian Gesuale highlights RKLB's vertical integration and expects positive EBITDA by 2027/2028, though notes integration risks from acquisitions.

$RKLBLowAI 9/10

Los Angeles Aerospace Manufacturing: Supply Chain Opportunities

Los Angeles County is seeing a surge in aerospace and defense contracts, totaling $7B in the past six months. Major recipients include Rocket Lab, Northrop Grumman, Caltech, SpaceX, Teledyne Technologies, and Canopy Aerospace. This boom creates opportunities for suppliers, as primes seek reliable, certified partners. The region's concentration of aerospace firms and talent pool positions it uniquely for growth.

$RKLBHighAI 8/10

Rocket Lab Stock Reverses 4.8%; Iridium’s FCC Review Is Only Starting

Rocket Lab (RKLB) shares fell 4.79% to $64.57 on Friday, after a 6.48% gain the previous day. The company raised $1.944 billion via a share offering, with 29.3 million new shares issued. The decline comes as the FCC begins its review of Rocket Lab's acquisition of Iridium (IRDM), with comments due by October 15. Iridium's shareholders will vote on the deal on September 24. Analysts have set price targets for RKLB ranging from $80 to $122.

$ASTSMedAI 8/10

ASTS, RKLB Stocks Sink To Multi-Month Lows While SPCX Holds Steady – Piper Sandler Says Elon Musk’s Company Is Yet To Prove Itself

AST SpaceMobile (ASTS) and Rocket Lab (RKLB) shares fell 15% and 10% respectively, while SpaceX (SPCX) held steady. Piper Sandler initiated coverage, rating ASTS 'Overweight' with a $100 target, RKLB 'Neutral' with an $83 target, and SPCX 'Neutral' with a $156 target. ASTS priced a $1B convertible note offering.